Nitric oxide based treatment of critical illness

The project aims to investigate new nitric oxide-based treatments for various disease states in animal experimental models, e.g. pulmonary hypertension and other organ failures. The project involves physiological, pharmacological and inflammatory measurement methods. The project may also include clinical studies of drug candidates in humans when they have developed so far. The project is partly carried out in collaboration with a small pharmaceutical company, Attgeno AB , of which Kristofer Nilsson is a co-founder and which was started thanks to research discoveries Kristofer Nilsson made during his PhD work.